Nevro Corp. (NVRO) Social Stream
NEVRO CORP (NVRO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering NEVRO CORP.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 12 | $160 | $105 | $127.909 | $30.82 | 315.02% |
| 2021-11-19 | 12 | $160 | $90 | $124.1 | $30.82 | 302.66% |
| 2021-12-06 | 12 | $160 | $90 | $124.1 | $30.82 | 302.66% |
| 2021-12-21 | 12 | $160 | $90 | $123.1 | $30.82 | 299.42% |
| 2022-01-03 | 12 | $160 | $90 | $120.6 | $30.82 | 291.3% |
| 2022-01-12 | 12 | $160 | $90 | $115.3 | $30.82 | 274.11% |
| 2022-02-07 | 12 | $160 | $90 | $113 | $30.82 | 266.65% |
| 2022-02-24 | 12 | $160 | $65 | $103.9 | $30.82 | 237.12% |
| 2022-03-01 | 13 | $160 | $65 | $98.727 | $30.82 | 220.33% |
| 2022-04-11 | 13 | $160 | $64 | $98 | $30.82 | 217.98% |
| 2022-04-13 | 13 | $160 | $64 | $96.5 | $30.82 | 213.11% |
| 2022-05-06 | 13 | $160 | $64 | $91.083 | $30.82 | 195.53% |
| 2022-05-24 | 13 | $160 | $64 | $90.25 | $30.82 | 192.83% |
| 2022-05-26 | 13 | $150 | $64 | $84.833 | $30.82 | 175.25% |
| 2022-06-07 | 11 | $116 | $55 | $76.4 | $30.82 | 147.89% |
| 2022-08-04 | 11 | $97 | $45 | $66.4 | $30.82 | 115.44% |
| 2022-09-17 | 10 | $97 | $45 | $66.4 | $30.82 | 115.44% |
| 2022-10-11 | 11 | $97 | $45 | $65.9 | $30.82 | 113.82% |
| 2022-10-12 | 11 | $97 | $31 | $62.727 | $30.82 | 103.53% |
| 2022-11-03 | 11 | $97 | $31 | $60.636 | $30.82 | 96.74% |
| 2022-11-18 | 11 | $97 | $31 | $59.818 | $30.82 | 94.09% |
| 2022-12-05 | 11 | $97 | $31 | $60.181 | $30.82 | 95.27% |
| 2022-12-12 | 11 | $97 | $31 | $56.272 | $30.82 | 82.58% |
| 2022-12-20 | 12 | $95 | $31 | $53.181 | $30.82 | 72.55% |
| 2023-01-06 | 12 | $95 | $31 | $52.545 | $30.82 | 70.49% |
| 2023-01-13 | 12 | $95 | $33 | $52.272 | $30.82 | 69.6% |
| 2023-01-26 | 12 | $95 | $33 | $52.181 | $30.82 | 69.31% |
| 2023-02-17 | 12 | $95 | $33 | $52.636 | $30.82 | 70.79% |
| 2023-02-26 | 12 | $95 | $33 | $52.09 | $30.82 | 69.01% |
The Trend in the Analyst Price Target
Over the past 47 weeks, NVRO's average price target has gone down $43.74.
NVRO reports an average of 50.5% for its upside potential over the past 47 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-11-03 | 11 | 97 | 31 | 59.818 | 41.69 | 43.48% |
| 2022-11-18 | 11 | 97 | 31 | 60.181 | 44.48 | 35.3% |
| 2022-12-12 | 11 | 97 | 31 | 56.272 | 40.51 | 38.91% |
| 2023-01-09 | 12 | 95 | 33 | 52.727 | 36.73 | 43.55% |
| 2023-02-26 | 12 | 95 | 33 | 52.090 | 31.95 | 63.04% |
NVRO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.83 | 3 | 0 | 6 | 1 | 1 | 12 |
The Trend in the Broker Recommendations
NVRO's average broker recommendation rating worsened by 0.33 over the prior 13 months.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for NVRO as an investment opportunity.
- In terms of how NEVRO CORP fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2656.37% of that group.
- NVRO has a greater number of analysts covering the stock than 2903.97% of stocks in the mid market cap category.
- In terms of how NEVRO CORP fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is higher than 2578.06% of that group.
- NVRO has a higher average analyst price target than 2556.33% of stocks in the mid market cap category.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to NEVRO CORP are ATRC, GMED, and NUVA.
View All Top Stocks by Price Target
Make investment decisions regarding NVRO using the data that counts. Try POWR Ratings for free.